ClinicalTrials.gg
Status unknownNCT03444571PRO-DIAGUpdated Feb 23, 2018

PRO-DIAG: Improved Diagnosis of Prosthetic Joint Infections

An interventional study of revision surgery in Prosthesis-Related Infections, sponsored by Aalborg University. Status unknown at 1 site in Denmark. Per ClinicalTrials.gov, last updated 2018-02-23.

Sponsored by Aalborg University · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Feb 2018), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Sex
All
01

Study summary

Implantation of joint prostheses is currently the second largest diagnosis-related group in the Danish health service, and in view of the demographic development and spread of lifestyle diseases, this type of intervention is expected to continue to increase.

Unfortunately, 5% of patients experience significant discomforts and complications. The second most frequent and serious complication is infection. While the established laboratory analyses (culture of tissue biopsies) are good at diagnosing acute infections, they are not satisfactory to diagnose a large group of patients especially with chronic infections. This can lead to prolonged diagnosing time and even to wrong diagnosis.

Several studies have shown that analyses of prosthetic parts and the use of molecular biological methods for detecting infecting microorganisms can significantly improve diagnostics accuracy.

The purpose of this project is primarily to demonstrate that analyses of bacterial specific DNA (16S rRNA genes) can confirm or rule out infection as fast (or faster) as cultivation methods. Rapid clarification can promote targeted treatment and in order to demonstrate this, the trial is conducted as a randomized study. .

02

Conditions studied

  • Prosthesis-Related Infections
03

In context

Prosthesis-Related Infections

35 studies on the registry are indexed under Prosthesis-Related Infections; 10 are open to participants now.

This study's planned enrollment of 40 is below the median of 193 across 20 interventional studies indexed under Prosthesis-Related Infections.

Browse Prosthesis-Related Infections studies →

Lead sponsor

Aalborg University is the lead sponsor of 183 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • revision of hip (THA) or knee replacement (TKA) on indication of likely infection

Exclusion criteria

Exclusion Criteria:

  • surgery within the last 4 months. The same applies to patients with short history of illness, pronounced acute symptoms and systemic response (reducing the likelihood of biofilm infection).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Platelets

Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
40 participants (estimated)

Study arms

  • No intervention
    Control
  • Experimental
    DNA based diagnosis

    Procedure: revision surgery

Interventions

  • Procedurerevision surgery

    If DNA based diagnosis detects infection, standard revision surgery will be conducted

06

What researchers measure

Primary outcomes

  1. Improved diagnostic accuracy

    DNA based method can detect patients with hidden chronic infections more often than culture

    Time frame: 6 months post surgery

07

Study locations

1 of 1 sites recruiting
  • Orthopedic surgery
    Aalborg, Northern Jutland 9000, Denmark
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2018 (actual). Primary completion is estimated for May 2019, 15 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 19, 2018
First posted
Feb 23, 2018
StartActual
Feb 16, 2018
Primary completionEst.
May 2019
CompletionEst.
Dec 2019
Last update
Feb 23, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 23, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03444571
Lead sponsor
Aalborg University
Responsible party
Yijuan Xu (Post Doc, Aalborg University) — Principal investigator
First posted
Feb 23, 2018
Start date
Feb 16, 2018
Primary completion
May 2019 (estimated)
Completion
Dec 2019 (estimated)
Last update
Feb 23, 2018

Study contacts

Yijuan Xu, PhD
Contact
xuyijuan@bio.aau.dk
004572201845

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion